JC-1
Suppliers
Names
[ CAS No. ]:
3520-43-2
[ Name ]:
JC-1
[Synonym ]:
5,6-Dichloro-2-[(1E)-3-(5,6-dichloro-1,3-diethyl-1,3-dihydro-2H-benzimidazol-2-ylidene)-1-propen-1-yl]-1,3-diethyl-1H-3,1-benzimidazol-3-ium iodide
1H-3,1-Benzimidazolium, 5,6-dichloro-2-[(1E)-3-(5,6-dichloro-1,3-diethyl-1,3-dihydro-2H-benzimidazol-2-ylidene)-1-propen-1-yl]-1,3-diethyl-, iodide (1:1)
5,6-dichloro-2-[3-(5,6-dichloro-1,3-diethyl-2(3H)-benzimidazolylidene)-1-propenyl]-1,3-diethylbenzimidazolium iodide
5,5',6,6'-tetrachloro-1,1',3,3'-tetraethyl-imidacarbocyanine iodide
5,5'6,6'-tetrachloro-1,1',3,3'-tetraethylbenzimidazolocarbocyanine iodide
1,1',3,3'-tetraethyl-5,5'6,6'-tetrachlorobenzimidazolocarbocyanine iodide
5,6-dichloro-2-<1-<3-(5,6-dichloro-1,3-diethyl-2-benzimidazolylidene)propenyl>>-1,3-diethylbenzimidazolium iodide
1,3,1',3'-Tetraethyl-5,6,5',6'-tetrachloro-2,2'-imidacarbocyanine iodide
5,6-Dichloro-2-[(1E)-3-(5,6-dichloro-1,3-diethyl-1,3-dihydro-2H-benzimidazol-2-ylidene)prop-1-en-1-yl]-1,3-diethyl-1H-3,1-benzimidazol-3-ium iodide
JC-1
5,5',6,6'-TETRACHLORO-1,1',3,3'-*TETRAETHYBENZIMIDA
Chemical & Physical Properties
[ Molecular Formula ]:
C25H27Cl4IN4
[ Molecular Weight ]:
652.225
[ Exact Mass ]:
650.003418
[ PSA ]:
18.67000
[ LogP ]:
4.15720
[ Storage condition ]:
-20℃
MSDS
Safety Information
[ Personal Protective Equipment ]:
Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter
[ RIDADR ]:
NONH for all modes of transport
Synthetic Route
Precursor & DownStream
Precursor
DownStream
Articles
J. Nutr. Biochem. 25(12) , 1254-62, (2014)
The n-3 polyunsaturated fatty acids eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) have been shown to enhance the effect of chemotherapeutic drugs in clinical studies in cancer patients an...
Toxicol. Appl. Pharmacol. 282(1) , 77-89, (2015)
The intracellular level of bilirubin (BR), an endogenous antioxidant that is cytotoxic at high concentrations, is tightly controlled within the optimal therapeutic range. We have recently described a ...
J. Exp. Med. 211(13) , 2549-66, (2014)
DOCK8 mutations result in an inherited combined immunodeficiency characterized by increased susceptibility to skin and other infections. We show that when DOCK8-deficient T and NK cells migrate throug...